跳至主要内容
临床试验/NCT07211451
NCT07211451已完成不适用

Low Axillary Nodal Metastasis Rates in Selected HER2-Positive and Triple-Negative Breast Cancer Patients: Toward De-escalation of Sentinel Lymph Node Biopsy

Gangnam Severance Hospital1 个研究点 分布在 1 个国家目标入组 1,571 人开始时间: 2025年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,571
试验地点
1
主要终点
Pathologic axillary lymph node metastasis rate

研究概览

简要总结

This study aimed to evaluated rates of pathologic axillary nodal metastasis in patients with with early-stage HER2-positive BC or TNBC who had clinically node-negative status on preoperative ultrasonography and underwent upfront breast-conserving surgery (BCS) with axillary surgery. In addition, this study aimed to identify subgroups in which SLNB omission may be feasible.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • HER2-positive breast cancer or TNBC
  • Patients who received upfront breast conserving surgery with axillary surgery
  • Patients who had a clinically axillary node negative disease

排除标准

  • Patients who underwent mastectomy
  • Absence of axillary nodal assessment on ultrasonography
  • Patients who underwent mastectomy
  • Patients who underwent mastectomy

结局指标

主要结局

Pathologic axillary lymph node metastasis rate

时间窗: Immediately after surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joon Jeong

Professpr

Gangnam Severance Hospital

研究点 (1)

Loading locations...

相似试验

Axillary Nodal Burden in HER2+ and TNBC | 临床试验